Artificial pancreas systems
03-21-2017 | Adolescents | Feature | Article
Adolescents: A challenging age group
Professor Moshe Phillip tells medwireNews why he believes the artificial pancreas will be of particular benefit for adolescents and young adults with type 1 diabetes.
Journal articles and book chapters
01-23-2017 | Type 1 diabetes | Review | Article
Closed-loop for type 1 diabetes – an introduction and appraisal for the generalist
Rapid progress over the past decade has been made with the development of the ‘Artificial Pancreas’, or closed-loop system. The recent FDA approval of the first hybrid closed-loop system makes the Artificial Pancreas a realistic therapeutic option for people with type 1 diabetes. In anticipation of its advent into clinical care, the authors provide a primer and appraisal of this novel therapeutic approach in type 1 diabetes for healthcare professionals and non-specialists in the field.
Bally L, Thabit H, & Hovorka R. BMC Med 2017;15:14. doi:10.1186/s12916-017-0794-8
Teenagers, Insulin pump2/© Medtronic, Fig. 1 A prototype closed-loop system. (a) A prototype closed-loop system comprises a continuous glucose monitor (CGM) sensor and receiver, an insulin pump, and a mobile phone running a control algorithm (potentially the algorithm may be located on the insulin pump obviating the need for a hand-held controller/mobile phone device). (b) A photo of a participant (obtained with consent) using the closed-loop system during a home study